Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MILTON FINEGOLD and DAVID MOORE.
MILTON FINEGOLD
Connection Strength
0.048
DAVID MOORE
  1. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology. 2013 Mar; 57(3):1098-106.
    View in: PubMed
    Score: 0.027
  2. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science. 2008 Nov 28; 322(5906):1395-9.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.